CMC Development
Ensuring pharmaceutical products are ready for every Stage
CMC gaps can delay approvals, increase costs and weaken investor confidence. KLIFO’s senior consultants step in to align science, manufacturing and regulatory compliance, taking ownership from strategy to execution. That’s how we keep your product ready for every stage.
CMC development from strategy to delivery
Chemistry, Manufacturing and Controls (CMC) is at the heart of successful drug development — transforming promising science into reliable, approvable medicines.
At KLIFO, we help leaders in biotech and pharma bridge the gap between potential and approval by providing highly experienced CMC consultants who not only understand processes, but take ownership and drive execution from strategy to delivery.
Put simply, CMC development ensures that every drug can be manufactured consistently, safely, and in compliance with global regulatory expectations.
In practice, it covers all aspects of how a drug is formulated, manufactured, controlled, packaged and stored. This process is essential throughout the development lifecycle — from the preclinical stage through to commercial supply — and is closely scrutinized by regulatory authorities such as FDA and EMA.
The complexity and criticality of CMC activities is often underestimated. While clinical data might drive investment, it’s the robustness of your CMC strategy that determines whether your product is approvable, scalable and commercially viable.
Without expert guidance, and hands-on management gaps in your CMC program can lead to:
- Regulatory approval delays (e.g. incomplete stability data or inadequate process validation)
- Increased costs due to rework and corrective actions
- Supply chain disruptions that undermine launch timelines
- Weak investor confidence if milestones slip unexpectedly
At KLIFO, we help you navigate this complexity with confidence. We identify and take ownership of your CMC challenges, working seamlessly alongside your team to resolve complexity and ensure regulatory maturity at every step.
Guidance through every phase
CMC activities don’t exist in isolation — they affect every stage, from preclinical planning to commercial supply.
Use the map to explore how our CMC expertise connects with each development phase, and how KLIFO supports you all the way to approval and beyond.
Typical deliverables
When you work with KLIFO, you gain more than advice—you gain execution. Our clients can expect:
- Implementation of tailored CMC development plans
- Regulatory-compliant documentation aligned with EMA, FDA and ICH requirements
- Analytical and manufacturing strategies that minimize risk and cost
- End-to-end project management to ensure timelines are met
- Embedded consultants who proactively identify risks and opportunities
Navigating the regulatory landscape
CMC development is inseparable from regulatory and quality compliance. At KLIFO, we work according to internationally recognised standards, including ICH guidelines (Q8–Q10) covering Quality by Design, risk management and quality systems, GMP manufacturing requirements, and the documentation framework defined in Module 3 of the CTD. Our expertise also covers the quality data packages required for IMPD and IND submissions, ensuring readiness for regulatory review in all major markets. As requirements evolve, our consultants stay ahead — guiding your project through every update with confidence.
The KLIFO promise
Great science deserves to reach patients – but success requires more than science. It takes experience, regulatory maturity and flawless execution.
When you work with KLIFO, you get senior professionals who take ownership. We embed into your team, apply vertical insight, and ensure your drug product is developed, documented and delivered right.
Ready to address your CMC development needs? Contact us today to speak directly with one of our senior experts.